AIM ImmunoTech Inc (NYSE American:AIM)

0.5951
Delayed Data
As of Jan 26
 +0.0049 / +0.83%
Today’s Change
0.29
Today|||52-Week Range
1.38
+90.80%
Year-to-Date
No recent news for AIM ImmunoTech Inc.

Today’s Trading

Previous close0.59
Today’s open0.61
Day’s range0.58 - 0.61
Volume270
Average volume (3 months)211,977
Market cap$31.4M
Data as of 3:57pm ET, 01/26/2023

Growth & Valuation

Earnings growth (last year)+10.66%
Earnings growth (this year)-5.83%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-17.18%
P/E ratioNM
Price/Sales322.61
Price/Book0.55

Competitors

 Today’s
change
Today’s
% change
LUMOLumos Pharma Inc-0.01-0.28%
SIOXSio Gene Therapies I...+0.00+0.71%
PPBTPurple Biotech Ltd-0.01-0.56%
ADMPAdamis Pharmaceutica...-0.00-1.21%
Data as of 3:59pm ET, 01/26/2023

Financials

Next reporting dateMarch 30, 2023
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$135.0K
Annual profit (last year)-$19.1M
Net profit margin-14,168.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Ocala, Florida

Forecasts